Femasys Inc
NASDAQ:FEMY
Femasys Inc
Net Issuance of Common Stock
Femasys Inc
Net Issuance of Common Stock Peer Comparison
Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors
Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Femasys Inc
NASDAQ:FEMY
|
Net Issuance of Common Stock
$15.3m
|
CAGR 3-Years
367%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Net Issuance of Common Stock
-$500m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-5%
|
|
Boston Scientific Corp
NYSE:BSX
|
Net Issuance of Common Stock
$199m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
Stryker Corp
NYSE:SYK
|
Net Issuance of Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbott Laboratories
NYSE:ABT
|
Net Issuance of Common Stock
-$674m
|
CAGR 3-Years
-50%
|
CAGR 5-Years
-59%
|
CAGR 10-Years
12%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Net Issuance of Common Stock
$310.2m
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
See Also
What is Femasys Inc's Net Issuance of Common Stock?
Net Issuance of Common Stock
15.3m
USD
Based on the financial report for Dec 31, 2023, Femasys Inc's Net Issuance of Common Stock amounts to 15.3m USD.
What is Femasys Inc's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 3Y
367%
Over the last year, the Net Issuance of Common Stock growth was 18 973%. The average annual Net Issuance of Common Stock growth rates for Femasys Inc have been 367% over the past three years .